Expression of pre-selected TMEMs with predicted ER localization as potential classifiers of ccRCC tumors. Issue 1 (December 2015)
- Record Type:
- Journal Article
- Title:
- Expression of pre-selected TMEMs with predicted ER localization as potential classifiers of ccRCC tumors. Issue 1 (December 2015)
- Main Title:
- Expression of pre-selected TMEMs with predicted ER localization as potential classifiers of ccRCC tumors
- Authors:
- Wrzesiński, Tomasz
Szelag, Malgorzata
Cieślikowski, Wojciech
Ida, Agnieszka
Giles, Rachel
Zodro, Elżbieta
Szumska, Joanna
Poźniak, Joanna
Kwias, Zbigniew
Bluyssen, Hans
Wesoly, Joanna - Abstract:
- Abstract Background VHL inactivation is the most established molecular characteristic of clear cell renal cell carcinoma (ccRCC), with only a few additional genes implicated in development of this kidney tumor. In recently published ccRCC gene expression meta-analysis study we identified a number of deregulated genes with limited information available concerning their biological role, represented by gene transcripts belonging to transmembrane proteins family (TMEMs). TMEMs are predicted to be components of cellular membranes, such as mitochondrial membranes, ER, lysosomes and Golgi apparatus. Interestingly, the function of majority of TMEMs remains unclear. Here, we analyzed expression of ten TMEM genes in the context of ccRCC progression and development, and characterized these proteins bioinformatically. Methods The expression of ten TMEMs (RTP3, SLC35G2, TMEM30B, TMEM45A, TMEM45B, TMEM61, TMEM72, TMEM116, TMEM207 andTMEM213 ) was measured by qPCR.T -test, Pearson correlation, univariate and multivariate logistic and Cox regression were used in statistical analysis. The topology of studied proteins was predicted with Metaserver, together with PSORTII, Pfam and Localizome tools. Results We observed significant deregulation of expression of 10 analyzed TMEMs in ccRCC tumors. Cluster analysis of expression data suggested the down-regulation of all tested TMEMs to be a descriptor of the most advanced tumors. Logistic and Cox regression potentially linked TMEM expression toAbstract Background VHL inactivation is the most established molecular characteristic of clear cell renal cell carcinoma (ccRCC), with only a few additional genes implicated in development of this kidney tumor. In recently published ccRCC gene expression meta-analysis study we identified a number of deregulated genes with limited information available concerning their biological role, represented by gene transcripts belonging to transmembrane proteins family (TMEMs). TMEMs are predicted to be components of cellular membranes, such as mitochondrial membranes, ER, lysosomes and Golgi apparatus. Interestingly, the function of majority of TMEMs remains unclear. Here, we analyzed expression of ten TMEM genes in the context of ccRCC progression and development, and characterized these proteins bioinformatically. Methods The expression of ten TMEMs (RTP3, SLC35G2, TMEM30B, TMEM45A, TMEM45B, TMEM61, TMEM72, TMEM116, TMEM207 andTMEM213 ) was measured by qPCR.T -test, Pearson correlation, univariate and multivariate logistic and Cox regression were used in statistical analysis. The topology of studied proteins was predicted with Metaserver, together with PSORTII, Pfam and Localizome tools. Results We observed significant deregulation of expression of 10 analyzed TMEMs in ccRCC tumors. Cluster analysis of expression data suggested the down-regulation of all tested TMEMs to be a descriptor of the most advanced tumors. Logistic and Cox regression potentially linked TMEM expression to clinical parameters such as: metastasis, Fuhrman grade and overall survival. Topology predictions classified majority of analyzed TMEMs as type 3 and type 1 transmembrane proteins, with predicted localization mainly in ER. Conclusions The massive down-regulation of expression of TMEM family members suggests their importance in the pathogenesis of ccRCC and the bioinformatic analysis of TMEM topology implies a significant involvement of ER proteins in ccRCC pathology. … (more)
- Is Part Of:
- BMC cancer. Volume 15:Issue 1(2015)
- Journal:
- BMC cancer
- Issue:
- Volume 15:Issue 1(2015)
- Issue Display:
- Volume 15, Issue 1 (2015)
- Year:
- 2015
- Volume:
- 15
- Issue:
- 1
- Issue Sort Value:
- 2015-0015-0001-0000
- Page Start:
- 1
- Page End:
- 18
- Publication Date:
- 2015-12
- Subjects:
- ccRCC -- Transmembrane proteins -- ER -- Gene expression -- Bioinformatics
Cancer -- Periodicals
616.994005 - Journal URLs:
- http://www.biomedcentral.com/bmccancer/ ↗
http://www.pubmedcentral.nih.gov/tocrender.fcgi?journal=16 ↗
http://link.springer.com/ ↗ - DOI:
- 10.1186/s12885-015-1530-4 ↗
- Languages:
- English
- ISSNs:
- 1471-2407
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - Digital store
British Library HMNTS - ELD Digital store - Ingest File:
- 9969.xml